A Pfizer scientist who reviewed Theranos' technology found the startup's assertions about it "not believable" and urged his company not to team with Theranos, according to evidence at Elizabeth Holmes' trial Friday. Despite that, Holmes passed along a report that made it look like Theranos' system had Pfizer's approval.